Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.

"Potential Conflicts of Interest Nothing to report."

"This study was supported by grants from the European Commission (FP7-241622), the European Leukodystrophy Association (ELA2009-041D6; ELA2008-040C4), the Spanish Institute for Health Carlos III (FIS PI080991 and FIS PI051118), and the Autonomous Government of Catalonia (2009SGR85) to A.P. The Centre for Biomedical Network Research on Rare Diseases is an initiative of the Spanish Institute for Health Carlos III. The study was developed under the COST action BM0604 (to A.P.). J.L-E. was a fellow of the Department of Education, Universities, and Research of the Basque Country Government (BFI07.126). S.F. was a fellow of the European Leukodystrophy Association (ELA 2007-018F4), and J.G. was a fellow of the Bellritge Institute of Biomedical Research program of PhD student fellowships. Work carried out at the Department of Experimental Medicine was supported in part by Research and Development grants from the Spanish Ministry of Science and Innovation (AGL2006-12433 and BFU2009-11879/BFI), the Spanish Ministry of Health (RD06/0013/0012 and PI081843), the Autonomous Government of Catalonia (2009SGR735), La Caixa Foundation, and COST B35 Action of the European Union. A.N. received a predoctoral fellowship from La Caixa Foundation."